Group One Trading, L.P. Intercept Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$9.99 - $18.71 $229,460 - $429,749	-22,969 Reduced 29.96%	53,694 $995,000
Q2 2023 Aug 09, 2023	BUY	$9.17 - $19.29 $147,627 - $310,549	16,099 Added 26.58%	76,663 $847,000
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $555,505 - $962,491	44,334 Added 273.16%	60,564 $813,000
Q4 2022 Feb 09, 2023	SELL	$11.61 - $16.11 $788,446 - $1.09 Million	-67,911 Reduced 80.71%	16,230 $200,000
Q3 2022 Nov 09, 2022	BUY	$12.21 - $19.7 $1.03 Million - $1.66 Million	84,141 New	84,141 $1.17 Million
Q2 2022 Aug 11, 2022	SELL	$11.23 - $19.59 $625,511 - $1.09 Million	-55,700 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$13.37 - $17.79 $544,653 - $724,711	40,737 Added 272.25%	55,700 $906,000
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $213,671 - $292,227	14,963 New	14,963 $244,000
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $4,835 - $11,868	-100 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$57.36 - $124.1 $3.06 Million - $6.61 Million	-53,300 Reduced 99.81%	100 $12,000
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $3.13 Million - $4.3 Million	53,400 New	53,400 $3.54 Million
Q3 2018 Nov 08, 2018	SELL	$88.49 - $127.55 $1.13 Million - $1.63 Million	-12,812 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $697,920 - $996,513	-11,632 Reduced 47.59%	12,812 $1.08 Million
Q1 2018 May 11, 2018	BUY	$52.72 - $67.25 $221,054 - $281,979	4,193 Added 20.71%	24,444 $1.5 Million
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $289,428 - $361,835	4,973 Added 32.55%	20,251 $1.18 Million
Q3 2017 Nov 15, 2017	BUY	$57.01 - $118.75 $631,328 - $1.32 Million	11,074 Added 263.42%	15,278 $887,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,204	4,204 $509,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account